Abstract:The GABAA receptor mainly mediates inhibitory signal transmission in mammalian central nervous systems and is the key target of sedative-hypnotics. However, the long-term use of sedativehypnotics often leads to drug resistance, necessitating the development of novel sedative-hypnotics. This development can be achieved with novel scaffolds designed via the computer-aided drug design methods to obtain significant advantages. In this study, robust virtual screening models were established by identifying effective positive allosteric modulators of the GABAA receptor from ChEMBL and BindingDB databases. These compounds combined with randomly extracted negative compounds were firstly applied for a 10 fold cross validation and grid search to establish machine learning models which were subsequently evaluated in an independent test set. In this step, 4 machine learning methods and 6 fingerprints were used to establish 24 models. In the test set, the CDK_LR model performed the best (MCC = 0.751) and was used for subsequent virtual screening. Two effective molecular docking models were also established based on conformation 6D6T and 6D6U, wherein the root mean square deviation (RMSD) values of redocking experiments were 1.141 and 1.505 & ANGS; (1 & ANGS; = 0.1 nm), respectively. During the virtual screening, 41112 compounds from a commercial database were scanned by machine learning, molecular docking, and molecular mechanics-generalized Born surface area models. After the screening, 16 hits were obtained, 4 of which were structurally novel positive hits verified by whole-cell patch-clamp electrophysiology experiments. The compound GPR120 was verified experimentally at both the cell and animal levels. In cortical neurons recombinantly expressing & alpha;1 & beta;2 & gamma;2-type receptors, at 10 and 50 & mu;mol & BULL;L-1, GPR120 could potentiate GABA EC3-10 current by 71.5% and 163.8%, respectively. Total decomposition contribution analysis and point mutation experiment showed that the key binding site between GPR120 and the GABAA receptor is H102, similar to that of the positive drug Diazepam. To further verify GPR120 function at the animal level, locomotor activity and loss of righting reflex (LORR) tests were performed. GPR120 inhibited the locomotor activity of mice, which recovered after 6 h, indicating that GPR120 is a moderate sedative. In the pentobarbital sodium-induced righting reflex hour test, GPR120 (20 mg & BULL;kg-1) significantly shortened the time to start LORR and prolonged its duration compared with the saline control group. In summary, using integrated virtual screening methods, GPR120 was identified as a moderate sedative with a novel scaffold.

HPLC-based activity profiling of Angelica pubescens roots for new positive GABAA receptor modulators in Xenopus oocytes

HPLC-based activity profiling approach for the discovery of GABAA receptor ligands using an automated two microelectrode voltage clamp assay on Xenopus oocytes

HPLC analysis and characteristic chromatograms of active components in different medicinal parts of Angelicae sinensis radix

Compounds From Angelica Keiskei With Nqo1 Induction, Dpph Center Dot Scavenging And Alpha-Glucosidase Inhibitory Activities

A System for Screening Agonists Targeting Β2-Adrenoceptor from Chinese Medicinal Herbs

GABA(A) receptor modulators from Chinese herbal medicines traditionally applied against insomnia and anxiety

Affinity ultrafiltration and UPLC-HR-Orbitrap-MS based screening of neuraminidase inhibitors from Angelica pubescens

Ligand fishing with cellular membrane-coated cellulose filter paper: a new method for screening of potential active compounds from natural products

Application of radioligand receptor binding assays in the search for CNS active principles from Chinese medicinal plants

Screening and Identification of Anti-Inflammatory Compounds from Erdong Gao via Multiple-Target-Cell Extraction Coupled with HPLC-Q-TOF-MS/MS and Their Structure–Activity Relationship

Simultaneous determination and pharmacokinetics of sixteen Angelicae dahurica coumarins in vivo by LC-ESI-MS/MS following oral delivery in rats

Chemical profiling and arginine kinase inhibitory activity of Angelica dahurica leaves

Pharmacological and phytochemical insights on the pancreatic β-cell modulation by Angelica L. roots

Paper-based Ligand Fishing Method for Rapid Screening and Real-time Capturing of α -Glucosidase Inhibitors from the Chinese Herbs

Integrating UPLC-MS/MS with in Silico and in Vitro Screening Accelerates the Discovery of Active Compounds in Stephania epigaea

[Isolation and Identification of the Ligustilide Compounds from the Root of Angelica Sinensis].

A Strategy for Qualitative and Quantitative Profiling of Angelicae Pubescentis Radix and Detection of Its Analgesic and Anti-Inflammatory Components by Spectrum-Effect Relationship and Multivariate Statistical Analysis.

Screening and analysis of the targeted compounds in Choerospondias axillaris extract by receptor chromatographic column with immobilized angiotensin II type 1 receptor

Identification of Novel GABAA Receptor Positive Allosteric Modulators with Novel Scaffolds Via Multistep Virtual Screening

Screening potential ligands of endothelin receptor A from Choerospondias axillaris and evaluation of their drug-like properties by affinity chromatographic methods

Characterization of the Anticoagulative Constituents of Angelicae Sinensis Radix and Their Metabolites in Rats by HPLC-DAD-ESI-IT-TOF-MSn.